#Singapore #Bio-Based #MojiaBio #A*STAR

Introduction

In a groundbreaking initiative, Singapore's Agency for Science, Technology and Research (ASTAR) has partnered with MojiaBio, an innovator in sustainable practices, to develop a state-of-the-art Sustainable Biomanufacturing Technology Platform (SBTP). With an investment of SGD 44.8 million, this partnership aims to produce eco-friendly bio-based molecules from renewable, low-cost resources, ultimately positioning Singapore at the forefront of the global bio-economy.

The Vision Behind the Initiative

This project aspires to create bio-based molecules that are not only sustainable but also cost-competitive with traditional chemical production methods. By utilizing materials such as methanol and ethylene glycol, the SBTP seeks to establish cost-parity with conventional processes, thus enabling widespread adoption across various industries, including textiles, automotive, personal care, and coatings.

Key Features of the SBTP

The SBTP's main innovation lies in its application of advanced synthetic biology and bioprocessing techniques. The platform aims to manufacture high-value bio-based products such as 1,3-propanediol (PDO), which is crucial for numerous applications ranging from skincare formulations to biodegradable plastics. Unlike traditional methods that rely heavily on fossil fuels, the SBTP leverages renewable resources, thus ensuring a lower carbon footprint and reduced environmental impact.

Benefits to Singapore's Economy

This initiative is set to bolster Singapore's leadership in sustainable biomanufacturing globally. The expected growth in the green chemicals market, estimated to reach USD 200 billion by 2030, highlights the immense potential for economic development and job creation within the green economy. By enhancing local capabilities in synthetic biology and biomanufacturing, Singapore aims to capture significant market share and foster new economic opportunities.

A Collaboration Rooted in Innovation

ASTAR and MojiaBio's collaboration is pivotal to achieving these goals. Dr. Ramon Gonzalez, Chief Science Officer of MojiaBio, emphasizes that the SBTP will also facilitate downstream research to synthesize high-value sustainable products tailored to industry needs. By integrating expertise from the ASTAR Singapore Institute of Food and Biotechnology Innovation (ASTAR SIFBI), the project fosters a synergistic approach to enzyme engineering and bioconversion processes.

Enhancing Production Efficiency

One of the key advancements of the SBTP is its ability to operate independently of host cell metabolism, a significant upgrade from conventional fermentation techniques. This operational autonomy not only boosts scalability but also enhances energy efficiency, making the production process more sustainable and cost-effective. The integration of computational modeling from the National University of Singapore (NUS) further optimizes enzyme and microbial strain engineering to serve as effective biocatalysts.

Commitment to Sustainable Practices

The SBTP aligns with Singapore's Green Plan 2030, which seeks to minimize carbon emissions and promote sustainability at all levels. The bio-based molecules produced through this initiative are projected to consume less energy and emit significantly lower carbon dioxide than traditional chemical processes, by approximately 60%.

Conclusion

This innovative collaboration between A*STAR and MojiaBio sets the stage for a sustainable future, showcasing how advanced science and technology can contribute to environmental conservation while fostering economic growth. As they strive for a circular bio-economy, both organizations invite like-minded entities to join their efforts in creating transformative solutions for a greener world. The establishment of MojiaBio's operational headquarters and dedicated research lab in Singapore signifies a long-term commitment to further advancing the region's biomanufacturing capabilities and securing its place as a leader in sustainable practices worldwide.